Top Buy
| Wertpapier ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | 35,20 € | 38,99 € | 10,76 % |
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | 136,15 € | 236,30 € | 73,56 % |
| Amedisys Inc. | 14 | 0 | 1 | 0 | 87,00 € | 92,26 € | 6,05 % |
| Amicus Therapeutics Inc. | 6 | 0 | 3 | 0 | 8,70 € | 17,78 € | 104,36 % |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | 21,18 € | 52,03 € | 145,63 % |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | 73,50 € | 75,94 € | 3,31 % |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | 93,08 € | - | - |
| Bruker Corp. | 8 | 1 | 2 | 0 | 67,20 € | 84,02 € | 25,04 % |
| CONMED Corp. | 11 | 1 | 1 | 0 | 67,50 € | 106,18 € | 57,30 % |
| Davita Inc. | 2 | 0 | 0 | 0 | 135,85 € | 124,89 € | -8,07 % |
| Ensign Group Inc. | 9 | 0 | 1 | 0 | 109,00 € | 116,99 € | 7,33 % |
| Exelixis Inc. | 18 | 0 | 3 | 0 | 18,72 € | 26,01 € | 38,96 % |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | 39,58 € | 47,17 € | 19,18 % |
| Healthequity Inc. | 1 | 0 | 0 | 0 | 72,00 € | 79,00 € | 9,72 % |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | 95,50 € | 124,85 € | 30,73 % |
| Insulet Corp. | 16 | 0 | 2 | 0 | 159,50 € | 215,54 € | 35,13 % |
| Masimo Corp. | 7 | 1 | 0 | 0 | 117,55 € | 147,62 € | 25,58 % |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | 358,90 € | 419,64 € | 16,92 % |
| Merit Medical Systems | 17 | 0 | 4 | 0 | 75,00 € | 86,90 € | 15,86 % |
| Myriad Genetics | 5 | 2 | 1 | 0 | 21,40 € | 25,14 € | 17,50 % |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | 1,27 € | 3,70 € | 190,65 % |
| Neurocrine Bioscience | 31 | 0 | 8 | 0 | 124,65 € | 140,60 € | 12,80 % |
| Novocure Ltd | 1 | 1 | 0 | 0 | 20,39 € | - | - |
| PTC Therapeutics Inc. | 15 | 8 | 3 | 3 | 33,20 € | 41,51 € | 25,04 % |
| Repligen Corp. | 13 | 0 | 1 | 0 | 144,35 € | 184,76 € | 27,99 % |